Concepedia

Lisa C. Satlin

LC

Statistics

Publications

3

Citations

126

H-Index

3

Active since

2009

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Lisa C. Satlin is an author at Novartis (United States) specializing in pharmacology, pharmacy, and pharmacotherapy.

Publications per year

2009–2019

3

Publications

3

Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study

John M. Flack, David A. Calhoun, Lisa C. Satlin et al. · Journal of Human Hypertension · 2009 · 80 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Pharmacokinetics, Safety Profile, and Efficacy of Aliskiren in Pediatric Patients With Hypertension

Janice E. Sullivan, Deborah Keefe, Yinong Zhou et al. · Clinical Pediatrics · 2013 · 25 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings

Oliver Kornmann, János Mucsi, Nadezda Kolosa et al. · Respiratory Medicine · 2019 · 21 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

1–3 of 3